As on Thursday, Elanco Animal Health Inc (NYSE: ELAN) started slowly as it slid -1.06% to $24.18, before settling in for the price of $24.44 at the close. Taking a more long-term approach, ELAN posted a 52-week range of $8.02-$24.84.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 29.95%. Meanwhile, its Annual Earning per share during the time was 29.95%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 2.53%. This publicly-traded company’s shares outstanding now amounts to $496.83 million, simultaneously with a float of $492.28 million. The organization now has a market capitalization sitting at $12.01 billion.
Elanco Animal Health Inc (ELAN) Ownership Facts and Figures
Another important factor to analyze is how key investors are playing towards the stock of the Drug Manufacturers – Specialty & Generic industry. Elanco Animal Health Inc’s current insider ownership accounts for 0.92%, in contrast to 115.51% institutional ownership. According to the most recent insider trade that took place on Dec 12 ’25, this organization’s Director bought 10,000 shares at the rate of 21.30, making the entire transaction reach 213,000 in total value, affecting insider ownership by 131,773. Preceding that transaction, on Dec 11 ’25, Company’s insider bought 4,500 for 21.33, making the whole transaction’s value amount to 95,985. This particular insider is now the holder of 123,082 in total.
Elanco Animal Health Inc (ELAN) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.35 per share during the current fiscal year.
Elanco Animal Health Inc’s EPS increase for this current 12-month fiscal period is 2.53% and is forecasted to reach 1.03 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 8.07% through the next 5 years, which can be compared against the 29.95% growth it accomplished over the previous five years trading on the market.
Elanco Animal Health Inc (NYSE: ELAN) Trading Performance Indicators
Let’s observe the current performance indicators for Elanco Animal Health Inc (ELAN). It’s Quick Ratio in the last reported quarter now stands at 1.23. Alongside those numbers, its PE Ratio stands at $331.69, and its Beta score is 1.87. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 2.62. Similarly, its price to free cash flow for trailing twelve months is now 32.65.
In the same vein, ELAN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.07, a figure that is expected to reach 0.11 in the next quarter, and analysts are predicting that it will be 1.03 at the market close of one year from today.
